https://chinapharmadesk.com/china-vbp-fujian-beijing-local-prices-payment-calendars-2026-11-12/2026-11-12T13:34:48.000Zhttps://oss.chinapharmadesk.com/2026/11/china-vbp-local-calendars-2026-11-12.jpgchina-vbp-local-calendars-2026-11-12.jpghttps://chinapharmadesk.com/china-innovative-drugs-hospital-formulary-payment-policy-2026-11-12/2026-11-12T13:30:16.000Zhttps://chinapharmadesk.com/brightgene-bgm0504-diabetes-phase3-semaglutide-1mg-2026-11-12/2026-11-12T13:28:56.000Zhttps://chinapharmadesk.com/charles-river-frontage-470m-take-private-business-split-2026-11-12/2026-11-12T12:58:40.000Zhttps://oss.chinapharmadesk.com/2026/11/frontage-transaction-2026-11-12.jpgfrontage-transaction-2026-11-12.jpghttps://chinapharmadesk.com/tyk-ty9591-huiyu-qilu-settlement-analysis-2026-11-12/2026-11-12T12:14:03.000Zhttps://oss.chinapharmadesk.com/2026/11/ty9591-en-path.jpgty9591-en-path.jpghttps://chinapharmadesk.com/qilu-qls5132-cldn6-adc-phase3-brief-2026-11-12/2026-11-12T12:14:02.000Zhttps://oss.chinapharmadesk.com/2026/11/qilu-en-card.jpgqilu-en-card.jpghttps://chinapharmadesk.com/haisco-hsk47388-oral-il23-phase3-brief-2026-11-12/2026-11-12T12:14:02.000Zhttps://oss.chinapharmadesk.com/2026/11/haisco-en-card.jpghaisco-en-card.jpghttps://chinapharmadesk.com/lilly-orforglipron-nmpa-oral-glp1-china-brief-2026-11-12/2026-11-12T12:14:01.000Zhttps://oss.chinapharmadesk.com/2026/11/orforglipron-en-card.jpgorforglipron-en-card.jpghttps://chinapharmadesk.com/china-tgct-beijiemai-hospital-reimbursement-analysis-2026-11-12/2026-11-12T08:41:30.000Zhttps://oss.chinapharmadesk.com/2026/11/china-tgct-hospital.jpgchina-tgct-hospital.jpghttps://chinapharmadesk.com/abbisko-pimicotinib-fda-merck-path-analysis-2026-11-12/2026-11-12T08:41:29.000Zhttps://oss.chinapharmadesk.com/2026/11/abbisko-merck-path.jpgabbisko-merck-path.jpghttps://chinapharmadesk.com/aasld-2026-mash-glp1-sirna-brief-2026-11-12/2026-11-12T08:41:28.000Zhttps://oss.chinapharmadesk.com/2026/11/aasld-mash.jpgaasld-mash.jpghttps://chinapharmadesk.com/yili-pharma-series-a-radiopharma-brief-2026-11-12/2026-11-12T08:41:27.000Zhttps://oss.chinapharmadesk.com/2026/11/yili-radiopharma.jpgyili-radiopharma.jpghttps://chinapharmadesk.com/highfield-tll-018-acr50-phase3-brief-2026-11-12/2026-11-12T08:41:27.000Zhttps://oss.chinapharmadesk.com/2026/11/highfield-ra.jpghighfield-ra.jpghttps://chinapharmadesk.com/abbisko-pimicotinib-fda-tgct-brief-2026-11-12/2026-11-12T08:41:26.000Zhttps://oss.chinapharmadesk.com/2026/11/abbisko-fda-brief.jpgabbisko-fda-brief.jpg